BioCatalyst

KYN-5356 low dose, KYN-5356 Medium Dose, KYN-5356 High Dose — catalyst calendar

1 verified catalyst event(s) referencing KYN-5356 low dose, KYN-5356 Medium Dose, KYN-5356 High Dose, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With
Phase 2 · Cognitive Impairment Associated With Schizophrenia (CIAS)
 Kynexis B.V. KYN-5356 low dose, KYN-5356 Medium Dose, ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.